PROTHENA CORP PUBLIC LTD CO (PRTA) › Cash & EquivalentsPROTHENA CORP PUBLIC LTD CO (PRTA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $02011: $02012: $124.86M2013: $176.68M2014: $293.58M2015: $370.59M2016: $386.92M2017: $417.62M2018: $427.66M2019: $375.72M2020: $295.38M2021: $579.09M2022: $710.41M2023: $618.83M2024: $471.39M2025: $307.53M$307.53M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$307.53M-34.8%2024$471.39M-23.8%2023$618.83M-12.9%2022$710.41M+22.7%2021$579.09M+96.1%2020$295.38M-21.4%2019$375.72M-12.1%2018$427.66M+2.4%2017$417.62M+7.9%2016$386.92M+4.4%2015$370.59M+26.2%2014$293.58M+66.2%2013$176.68M+41.5%2012$124.86M—2011$0—2010$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share